|
|
|
Sunday, March 21, 2010 — 8:30 AM, Thurgood North East
|
- 25th Anniversary of the Society for Cardiovascular Pathology: An Update on Endomyocardial Biopsy
|
|
Moderators:
|
Michael C. Fishbein, University of California, Los Angeles, CA and
Gaetano Thiene, University of Padua Medical School, Padua, Italy
|
|
|
Disclosure:
|
In accordance with ACCME guidelines regarding disclosure, the USCAP policy requires that faculty members who have a significant financial or other relationship with a commercial company, entity, or service (which will be discussed in this Symposium) must disclose this to attendees. The Academy also requires that speakers disclose any products that are not labeled for the use under discussion. Jeffrey Saffitz has a patent pending for ARVC. The other speakers listed below have indicated they have nothing to disclose.
|
Click the button above to add this event to your Itinerary Planner...
| 8:30 | Modern Classification of Cardiomyopathies - Cristina Basso, University of Padua Medical School, Padua, Italy |
| 9:00 | Endomyocardial Biopsy: When and How - John P. Veinot, Ottawa Hospital, Ottawa, Canada |
| 9:30 | Myocarditis: Dallas Criteria Revisited - John T. Fallon, The Mount Sinai Medical Center, New York, NY |
| 10:00 | Break |
| 10:30 | Treatment and Prognosis of Myocarditis and Cardiomyopathies - Mariell Jessup, University of Pennsylvania, Philadelphia, PA |
| 11:00 | Endomyocardial Biopsy for Rejection Monitoring of Cardiac Transplantation - Gayle L. Winters, Brigham and Women's Hospital, Boston, MA |
| 11:30 | DISTINGUISHED ACHIEVEMENT AWARD LECTURE: Molecular Basis of heart Muscle Disease - Insights from Endomyocardial Biopsies, Whole Hearts, Body Fluids and Model Systems - Bruce McManus, St. Paul's Hospital, Vancouver, British Columbia, Canada |
|
Twenty Five years elapsed since the foundation of the Society for Cardiovascular Pathology. The Session of the Companion Meeting 2010 will be a celebration of the event and endomyocardial biopsy was chosen as the topic of the Symposium. The possibility to study the myocardium in living patients through endomyocardial biopsy made a revolution for the discipline of Cardiovascular Pathology. It is accomplished in cases of acute, non ischemic heart failure, especially when myocarditis is suspected, in ventricular arrhythmias of otherwise unexplained case, in cardiac masses and in the monitoring of cardiac transplantation. Dallas criteria for diagnosis of active myocarditis and classification of cardiomyopathies will be revisited. The need to include molecular investigations in the cardiovascular pathology armamentarium will be discussed as well as clinical implication of bioptic findings in terms of treatment anc prognosis. |
|
|
|
